Biomerieux SA (BIOX.PA)
BIOX.PA on Paris Stock Exchange
74.15EUR
4:35pm BST
74.15EUR
4:35pm BST
Change (% chg)
€-0.35 (-0.47%)
€-0.35 (-0.47%)
Prev Close
€74.50
€74.50
Open
€74.50
€74.50
Day's High
€74.60
€74.60
Day's Low
€73.40
€73.40
Volume
113,996
113,996
Avg. Vol
111,181
111,181
52-wk High
€82.60
€82.60
52-wk Low
€53.10
€53.10
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Dec '18 | 1,252.10 | 1.030 |
| Jun '18 | 1,169.20 | 1.140 | |
| FY 2017 | Dec '17 | 1,153.90 | 1.162 |
| Jun '17 | 1,134.30 | 0.854 |
*Note: Units in Millions ofEuro
**Note: Units in Euro
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-19 | 1 | 1,260.90 | 1,260.90 | 1,260.90 | -- |
| Quarter Ending Dec-19 | 2 | 1,965.75 | 2,583.00 | 1,348.50 | 2,583.00 |
| Year Ending Dec-19 | 13 | 2,626.34 | 2,677.00 | 2,546.00 | 2,593.71 |
| Year Ending Dec-20 | 13 | 2,812.43 | 2,882.00 | 2,754.00 | 2,778.44 |
| Earnings (per share) | |||||
| Quarter Ending Jun-19 | 1 | 1.10 | 1.10 | 1.10 | -- |
| Quarter Ending Dec-19 | 2 | 1.70 | 2.09 | 1.31 | 2.09 |
| Year Ending Dec-19 | 13 | 2.33 | 2.42 | 2.23 | 2.35 |
| Year Ending Dec-20 | 13 | 2.63 | 2.74 | 2.40 | 2.61 |
| LT Growth Rate (%) | 3 | 9.70 | 10.90 | 8.90 | 12.95 |
Sales and Profit Figures in Euro (EUR);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | 42.79 | 32.13 | 32.55 | |
| P/E High - Last 5 Yrs. | 39.24 | 40.21 | 48.11 | |
| P/E Low - Last 5 Yrs. | 18.33 | 19.56 | 23.41 | |
| Beta | 0.36 | 0.79 | 0.87 | |
| Price to Sales (TTM) | 3.73 | 6.67 | 8.44 | |
| Price to Book (MRQ) | 5.10 | 4.94 | 5.27 | |
| Price to Tangible Book (MRQ) | 11.47 | 16.52 | 6.74 | |
| Price to Cash Flow (TTM) | 22.97 | 21.65 | 24.12 | |
| % Owned Institutions | -- | 4.69 | 1.65 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | 0.47 | 1.05 | 1.35 | |
| Dividend Yield - 5 Year Avg | 1.03 | 1.26 | 1.37 | |
| Dividend 5 Year Growth Rate | 0.41 | 16.18 | 4.71 | |
| Payout Ratio(TTM) | 20.31 | 30.83 | 39.59 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | 13.34 | 8.64 | 13.45 | |
| Sales (TTM) vs TTM 1 Yr. Ago | 10.06 | 2.20 | 8.04 | |
| Sales - 5 Yr. Growth Rate | 8.06 | 8.62 | 10.84 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 18.11 | 59.83 | 48.19 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 42.93 | -- | -- | |
| EPS - 5 Yr. Growth Rate | 2.55 | 19.53 | 10.46 | |
| Capital Spending - 5 Yr. Growth Rate | 17.94 | 7.98 | 14.68 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | 1.18 | 2.44 | 2.18 |
| Current Ratio (MRQ) | 1.82 | 3.17 | 2.98 |
| LT Debt to Equity (MRQ) | 23.01 | 29.40 | 11.35 |
| Total Debt to Equity (MRQ) | 31.38 | 36.33 | 16.04 |
| Interest Coverage (TTM) | 10.28 | 15.67 | 28.45 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | 53.06 | 58.68 | 52.36 | |
| Gross Margin - 5 Yr. Avg. | 51.19 | 58.15 | 50.39 | |
| EBITD Margin (TTM) | 20.93 | -- | -- | |
| EBITD - 5 Yr. Avg | 20.41 | 22.91 | 12.41 | |
| Operating Margin (TTM) | 13.41 | 17.63 | 5.62 | |
| Operating Margin - 5 Yr. Avg. | 13.13 | 15.80 | 8.00 | |
| Pre-Tax Margin (TTM) | 12.38 | 17.42 | 4.64 | |
| Pre-Tax Margin - 5 Yr. Avg. | 12.22 | 16.06 | 8.28 | |
| Net Profit Margin (TTM) | 8.72 | 13.30 | 1.37 | |
| Net Profit Margin - 5 Yr. Avg. | 8.13 | 11.21 | 4.69 | |
| Effective Tax Rate (TTM) | 29.58 | 23.20 | 22.13 | |
| Effective Tax Rate - 5 Yr. Avg. | 33.49 | 28.88 | 22.58 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 228,095 | 28,867,337 | 819,624,671 | |
| Net Income/Employee (TTM) | 19,886 | 3,199,994 | 92,776,869 | |
| Receivable Turnover (TTM) | 5.23 | 5.07 | 5.82 | |
| Inventory Turnover (TTM) | 2.67 | 3.32 | 3.42 | |
| Asset Turnover (TTM) | 0.79 | 0.79 | 0.90 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | 6.86 | 10.43 | 10.65 | |
| Return on Assets - 5 Yr. Avg. | 6.14 | 8.95 | 11.77 | |
| Return on Investment (TTM) | 8.88 | 13.70 | 13.82 | |
| Return on Investment - 5 Yr. Avg. | 8.26 | 11.59 | 15.32 | |
| Return on Equity (TTM) | 12.39 | 16.39 | 15.24 | |
| Return on Equity - 5 Yr. Avg. | 10.90 | 13.89 | 16.41 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | 7.05 | 9.82 | 8.06 |
| EPS (TTM) % | 62.50 | 3.04 | 2.55 |
| Dividend % | 0.00 | 0.00 | 0.41 |
Note: Units in Millions of US Dollars
Performance for Biomerieux SA
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | 3.11 | -1.63 | 99 | 52 |
| 13 Week | 12.46 | 7.95 | 99 | 73 |
| 26 Week | 33.50 | 27.90 | 99 | 63 |
| 52 Week | 58.38 | 32.38 | 99 | 42 |
| YTD | 49.11 | 35.27 | 99 | 41 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 19.30% |
| # of Holders: | 239 |
| Total Shares Held: | 22,843,935 |
| 3 Mo. Net Change: | -340,952 |
| # New Positions: | 7 |
| # Closed Positions: | 13 |
| # Increased Positions: | 53 |
| # Reduced Positions: | 69 |
| # Net Buyers: | -16 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.